The authors would like to acknowledge the assistance and collaboration of the following individuals and teams. In particular, Joseph Burns, Charles Thickstun and Manosila Yoganathan (Bruyère Research Institute); Maddi Djara (Indonesia); Zebedee Kerry (Papua New Guinea); Drs. K. Kristhnamoorthy and S. Subramanian (India); Kobie K. O’Brian (Washington University in St. Louis); Santosh Wale and Syngene International (India); the Vector Control Research Centre research safety trial team (India); Papua New Guinea Institute of Medical Research safety trial team; Fiji Integrated Therapy Acceptability team; IMA World Health team in Haiti; Puskesmas staff in Sumba Barat Daya; our interviewers, our drivers and the Health Departments and the communities where we worked in each country.
The content of this publication is solely the responsibility of the authors and does not represent the official views of the Bill & Melinda Gates Foundation or MSD. Also, the opinions expressed in this article are the authors’ own and do not reflect the view of the Centers for Disease Control and Prevention, the Department of Health and Human Services, or the United States government.